Contact Uscontact

Parc Euromédecine, Cap Gamma
1682 Rue de la Valsière - CS17383
34189 Montpellier cedex 4 - FRANCE

Office +33 (0)4 67 727 670
FAX : +33 (0)4 67 727 679

Out-LicensingOut-Licensing 

3 oncology-focused projects, including novel targeted therapies (molecules and antibodies), under development and potentially available for licensing or collaboration.
» Read more ...

Newsrss

04/25/13 : OriBase Pharma is entitled to taxes return for investment

Thanks to a first round of fund raising realized successfully ( 1 500 000€), involving 52 investors, we were able...
» Read more ...

The Creation of OriBase Pharma

test image 2

OriBase Pharma is the result of the merger between Nova Decision and Azasynth. In 2010, the two companies joined forces in new headquarters in Montpellier, France. Before the merger, both companies were young biotech start-ups, created in 2007.

Today, OriBase Pharma consists of 10 employees: 8 within R&D and 2 within Business Development and Administration.

test image 2

History

Created in 2007, OriBase Pharma is a biotechnology-pharma company, specialized in the development of new targeted therapies in oncology. The company results from the strategic merger in October 2010 between two innovative companies that decided to complement their technology, assets and expertises:

In January 2011 OriBase Pharma employees relocated to the new facilities at the Biopôle of Montpellier. OriBase Pharma now has an extensively equipped research laboratory of 355 m2 (3821 sq ft) to ensure the continuity of its research programs.